Page of

The Commercialization of Phase I Trials

The Commercialization of Phase I Trials

Chapter:
(p.100) 4 The Commercialization of Phase I Trials
Source:
Adverse Events
Author(s):
Jill A. Fisher
Publisher:
NYU Press
DOI:10.18574/nyu/9781479877997.003.0005

Shifting focus from the healthy volunteers to the clinics themselves, Chapter 4 provides a brief history of the Phase I industry to contextualize the opportunistic nature of many of the clinics that are currently operating in the United States. Clinics’ concerns about profitability and/or reputation lead to different investments in their facilities and staffing, which in turn result in a wide variation in experiences for healthy volunteers depending on where they enroll. In short, some clinics are perceived as state-of-the-art facilities that are comfortable and professional spaces, whereas others are rundown and have few amenities, indicating that participants’ needs are clearly not the priority. The material configurations of Phase I clinics communicate to healthy volunteers important messages about their safety and worth.

Keywords:   Phase I industry, United States, clinic space, capitalism, pharmaceutical industry, material investment

Sign In

Copyright © 2021. All rights reserved.
Privacy Policy and Legal Notice